Hamburg, Germany

Kai Bartkowiak

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Panka Cancer Research Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Bartkowiak. Retrieved from https://idiyas.com/inventor/kai-bartkowiak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kai Bartkowiak: Cancer Detection Innovation

Introduction

Kai Bartkowiak is an inventor associated with Hamburg, Germany. His work includes a patent describing a method for detecting breast cancer or breast cancer cells by examining Cyr61 in a liquid sample.

Latest Patents

Bartkowiak is associated with 1 patent, titled “Method of Detecting Cancer or Cancer Cells.” The invention describes obtaining a liquid sample containing cells, microvesicles, and/or exosomes from a subject, with blood or bone marrow aspirate specified as sample sources. It then determines whether soluble or cell-surface-associated Cyr61 is present, using ELISA for detection.

Career Highlights

The provided information associates Bartkowiak with Panka Cancer Research AG and Panka Blood Test GmbH. His patent focuses on a biomarker-based approach to detecting breast cancer or cancer cells.

Collaborations

Klaus Pantel is identified as Bartkowiak’s coworker.

Conclusion

Kai Bartkowiak’s recorded patent work centers on detecting breast cancer through Cyr61 analysis in liquid samples, reflecting an application of biomarker testing to cancer research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…